Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
| Imported - Imported |
Individuals with advanced-stage laryngeal cancer at diagnosis were more likely to be uninsured or covered by Medicaid than to have private insurance.
According to a report in the August issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.
"Laryngeal [voice box] cancer is diagnosed in nearly 10,000 men and women in the United States annually and is among the most common cancers in the upper aerodigestive tract," according to background information in the article. Stage at diagnosis is a key factor influencing prognosis and treatment. "It is plausible that individuals without health insurance or with other barriers to health care access would be less likely to seek medical attention for these symptoms and thus present at a later stage with worse survival and fewer options for treatment."
Amy Y. Chen, M.D., M.P.H., of Emory University and the American Cancer Society, Atlanta, and colleagues analyzed medical and insurance information from 61,131 patients diagnosed between 1996 and 2003 to examine the relationship between patients' insurance status and overall stage of cancer and tumor size at diagnosis. Stage at diagnosis was categorized as early (stages I and II) or advanced (stages III and IV) and tumor size (T stage) at diagnosis was categorized as T1, T2, T3 or T4, with T4 being the largest. Patient race, sex, age, US census region of residence, education and ZIP code as well as type of treatment facility were also noted.
"There were 32,665 (53.4 per cent) [patients] with early-stage disease and 28,466 (46.6 per cent) with advanced-stage disease. The distribution of T stage included 22,693 (37.1 per cent) with T1 disease, 15,111 (24.7 per cent) with T2 disease, 13,541 (22.2 per cent) with T3 disease and 9,786 (16 per cent) with T4 disease," the authors write. "Patients with advanced-stage disease or more advanced T stage were more likely to be uninsured or have Medicaid or other government-funded plans than were those with early-stage disease."
Patients who were female, black, between ages 18 and 56 or who live in ZIP codes with low proportions of high school graduates or with low median household incomes were more likely to be diagnosed with an advanced stage of the disease and/or larger tumors. Those treated at teaching/research facilities were also more likely to have advanced disease.
"In conclusion, our analyses provide the first assessment, to our knowledge, of the strong association between medical insurance and stage of laryngeal cancer at diagnosis among a large, generalizable cohort. Insurance coverage is a highly modifiable factor that affects not only tumor associated morbidity and mortality but also quality of life and economic costs," the authors conclude.
"Laryngeal [voice box] cancer is diagnosed in nearly 10,000 men and women in the United States annually and is among the most common cancers in the upper aerodigestive tract," according to background information in the article. Stage at diagnosis is a key factor influencing prognosis and treatment. "It is plausible that individuals without health insurance or with other barriers to health care access would be less likely to seek medical attention for these symptoms and thus present at a later stage with worse survival and fewer options for treatment."
Amy Y. Chen, M.D., M.P.H., of Emory University and the American Cancer Society, Atlanta, and colleagues analyzed medical and insurance information from 61,131 patients diagnosed between 1996 and 2003 to examine the relationship between patients' insurance status and overall stage of cancer and tumor size at diagnosis. Stage at diagnosis was categorized as early (stages I and II) or advanced (stages III and IV) and tumor size (T stage) at diagnosis was categorized as T1, T2, T3 or T4, with T4 being the largest. Patient race, sex, age, US census region of residence, education and ZIP code as well as type of treatment facility were also noted.
"There were 32,665 (53.4 per cent) [patients] with early-stage disease and 28,466 (46.6 per cent) with advanced-stage disease. The distribution of T stage included 22,693 (37.1 per cent) with T1 disease, 15,111 (24.7 per cent) with T2 disease, 13,541 (22.2 per cent) with T3 disease and 9,786 (16 per cent) with T4 disease," the authors write. "Patients with advanced-stage disease or more advanced T stage were more likely to be uninsured or have Medicaid or other government-funded plans than were those with early-stage disease."
Patients who were female, black, between ages 18 and 56 or who live in ZIP codes with low proportions of high school graduates or with low median household incomes were more likely to be diagnosed with an advanced stage of the disease and/or larger tumors. Those treated at teaching/research facilities were also more likely to have advanced disease.
"In conclusion, our analyses provide the first assessment, to our knowledge, of the strong association between medical insurance and stage of laryngeal cancer at diagnosis among a large, generalizable cohort. Insurance coverage is a highly modifiable factor that affects not only tumor associated morbidity and mortality but also quality of life and economic costs," the authors conclude.
Related Articles/Posts
Tags: Patients - with - Medicaid - and - those - lacking - insurance - have - higher - risk - of - advanced - laryngeal - cancer
Set as favorite
Bookmark
Email this
Hits: 387
Trackback(0)
Comments (0)

Write comment





